Provided by Tiger Fintech (Singapore) Pte. Ltd.

TransMedics Group, Inc.

87.72
-0.5200-0.59%
Post-market: 87.950.2300+0.26%18:23 EDT
Volume:885.16K
Turnover:77.75M
Market Cap:2.95B
PE:86.85
High:89.33
Open:87.85
Low:86.14
Close:88.24
Loading ...

TransMedics Group (NasdaqGM:TMDX) Surges 20% Over Last Month

Simply Wall St.
·
13 Apr

TransMedics Group, Inc. (TMDX): A Bull Case Theory

Insider Monkey
·
08 Apr

Trump Tariffs Will Sow Long-term Structural Dislocation, Oppenheimer Says

MT Newswires Live
·
08 Apr

TransMedics Group And 2 Other Stocks That May Be Trading Below Estimated Value

Simply Wall St.
·
04 Apr

Is Transmedics’ (TMDX) Long-Term Growth Potential Still Intact?

Insider Monkey
·
02 Apr

Piper Sandler Remains a Buy on TransMedics Group (TMDX)

TIPRANKS
·
02 Apr

TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

Simply Wall St.
·
28 Mar

TransMedics Group (TMDX) Missed Expectations Due to Seasonality

Insider Monkey
·
25 Mar

TransMedics Group (TMDX) Slid as Results Fell Short of Expectations

Insider Monkey
·
17 Mar

TransMedics Group Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
11 Mar

Stock Track | TransMedics Group Soars 5.22% on Upbeat Q4 Results and Positive Outlook

Stock Track
·
05 Mar

TransMedics Group (NasdaqGM:TMDX) Sees 3% Price Rise As Revenue Hits US$122M In Strong Q4 2024

Simply Wall St.
·
05 Mar

Piper Sandler Sticks to Its Buy Rating for TransMedics Group (TMDX)

TIPRANKS
·
04 Mar

Morgan Stanley Reaffirms Their Hold Rating on TransMedics Group (TMDX)

TIPRANKS
·
03 Mar

Transmedics Group Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Mar

Is TransMedics Group, Inc. (TMDX) the Worst Performing Mid Cap Stock to Buy According to Analysts?

Insider Monkey
·
01 Mar

TransMedics Stock Rises as Q4 Earnings & Revenues Beat Estimates

Zacks
·
01 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Recursion Pharmaceuticals, DoubleVerify Holdings, Praxis Precision Medicines

Reuters
·
28 Feb

Stock Track | TransMedics Group Soars 6.77% in Pre-Market on Stellar Q4 Results, Robust 2025 Outlook

Stock Track
·
28 Feb

BUZZ-TransMedics climbs on Q4 revenue beat

Reuters
·
28 Feb